BIO-TECHNE Corp Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
BIO-TECHNE Corp (TECH) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $475.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-08-24
- BIO-TECHNE Corp unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2026 was $475.00K, a 75.64% decline from fiscal 2025.
- BIO-TECHNE Corp unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $1.95M.
- BIO-TECHNE Corp unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $357.00K, a 54.11% decline from fiscal 2021.
- BIO-TECHNE Corp unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $778.00K, a 25.26% decline from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2026-06-30 | $475.00K 10-K · filed 2026-08-24 | |
| 2025-06-30 | $1.95M 10-K · filed 2026-08-24 | |
| 2022-06-30 | $357.00K 10-K · filed 2024-08-22 | |
| 2021-06-30 | $778.00K 10-K · filed 2023-08-23 | |
| 2020-06-30 | $1.04M 10-K · filed 2022-08-24 | $778.00K 10-K · filed 2021-08-25 |
| 2019-06-30 | $1.04M 10-K · filed 2021-08-25 | |
| 2018-06-30 | $0.00 10-K · filed 2021-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |